Drug intelligence / Profile preview

human peripheral blood-derived induced neural stem cells

Development stage: Unknown
Lead developer: Beijing Allife Medicine Technology
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intracerebral

Overview

This cell therapy consists of induced neural stem cells (iNSCs) derived from human peripheral blood, developed by Allife Medical Science and Technology Co., Ltd. It is specifically designed for the treatment of chronic cerebral hemorrhagic stroke. The therapy involves the direct intracerebral transplantation of these cells into the affected brain regions. The mechanism of action is multifaceted, involving neuroprotection of existing brain tissue, immunomodulation to reduce secondary injury, and potential cell replacement to restore lost neural circuits. It is currently being evaluated in a Phase 1 clinical trial to assess safety and preliminary efficacy.

Other names: Induction of neural stem cellsiNSC transplantation

Beyond the preview

Go deeper on human peripheral blood-derived induced neural stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on human peripheral blood-derived induced neural stem cells.

Explore the full profile